Transient Ischemic Attack Clinical Trials

19 recruiting

Transient Ischemic Attack Trials at a Glance

29 actively recruiting trials for transient ischemic attack are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Beijing, Anyang, and Beijing. Lead sponsors running transient ischemic attack studies include Beijing Tiantan Hospital, Capital Medical University, and Bakulev Scientific Center of Cardiovascular Surgery.

Browse transient ischemic attack trials by phase

Treatments under study

About Transient Ischemic Attack Clinical Trials

Looking for clinical trials for Transient Ischemic Attack? There are currently 19 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transient Ischemic Attack trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transient Ischemic Attack clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 29 trials

Recruiting

Florbetaben for Imaging of Vascular Amyloid

StrokeAcute Coronary SyndromeTransient Ischemic Attack+1 more
Ottawa Heart Institute Research Corporation30 enrolled1 locationNCT06091319
Recruiting
Not Applicable

Pharmacogenomics in Stroke: Feasibility of CYP2C19 Testing

StrokeTransient Ischemic Attack (TIA)
University of Alabama at Birmingham200 enrolled1 locationNCT06943586
Recruiting
Not Applicable

Ambulatory Stroke Unit Treatment for Elderly Patients

Ischemic StrokeTransient Ischemic Attack (TIA)
University Hospital Heidelberg400 enrolled1 locationNCT07420374
Recruiting

Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis

Ischemic StrokeTransient Ischemic Attack
Capital Medical University1,300 enrolled1 locationNCT07242768
Recruiting
Not Applicable

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Ischemic StrokeTransient Ischemic Attack (TIA)
Beijing Tiantan Hospital4,490 enrolled3 locationsNCT06783049
Recruiting

Diagnosis of Transient Ischemic Attacks in the Emergency Department

Cardiovascular MorbidityTransient Ischemic Attack
University Hospital, Strasbourg, France300 enrolled1 locationNCT07339787
Recruiting
Not Applicable

Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China

Ischemic StrokeTransient Ischemic Attack (TIA)
Beijing Tiantan Hospital4,000 enrolled1 locationNCT07143149
Recruiting
Not Applicable

Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors

Stroke (CVA) or Transient Ischemic Attack
Lahore University of Biological and Applied Sciences36 enrolled2 locationsNCT07266662
Recruiting
Not Applicable

Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke

StrokeStroke (CVA) or Transient Ischemic Attack
Kessler Foundation45 enrolled1 locationNCT07113041
Recruiting
Not Applicable

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

DeathStrokeTransient Ischemic Attack+2 more
Bakulev Scientific Center of Cardiovascular Surgery158 enrolled1 locationNCT06253000
Recruiting
Phase 2Phase 3

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences100 enrolled1 locationNCT06653348
Recruiting

Types of Intracellular Bacteria in Atherosclerotic Plaques and Analysis of Risk Factors

DiabetesCarotid Artery StenosisHyperlipidemia+6 more
Tang-Du Hospital200 enrolled1 locationNCT06935279
Recruiting
Not Applicable

Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke

Atrial FibrillationHypertensionIschemic Stroke+2 more
Jukka Putaala405 enrolled4 locationsNCT03710902
Recruiting

Stroke-Card Registry

Ischemic StrokeTransient Ischemic Attack
VASCage GmbH5,000 enrolled2 locationsNCT04582825
Recruiting
Not Applicable

Integrated Approach in Frail Older People with Atrial Fibrillation

Heart FailureDiabetes MellitusHypertension+7 more
Heart Care Foundation1,250 enrolled50 locationsNCT06775028
Recruiting
Not Applicable

Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke

Atrial FibrillationTransient Ischemic AttackIschemic Stroke, Cryptogenic
Technical University of Munich400 enrolled1 locationNCT06005233
Recruiting

Canadian TIA Score Versus ABCD2 Score in Risk Stratification of Transient Ischemic Attack (TIA)

Transient Ischemic Attack (TIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna800 enrolled1 locationNCT06718075
Recruiting
Not Applicable

Genotype Guided Antiplatelet Therapy in Ischemic Stroke

Ischemic StrokeTransient Ischemic Attack
National Neuroscience Institute350 enrolled1 locationNCT05763862
Recruiting
Phase 4

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

Cardiovascular DiseasesIschemic StrokeCerebrovascular Disease+3 more
Seoul National University Hospital200 enrolled32 locationsNCT05995600
Recruiting

Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke

Stroke, IschemicTransient Ischemic AttackCoagulation Disorder
Cwm Taf University Health Board (NHS)360 enrolled1 locationNCT05645081